Central Pharmaceutical seeking strategic investors to develop North American mar

David Shi, deputy chairman of Shanxi Central Pharmaceutical International 
(0327), said the company has invested RMB20mln to set up 22 points for market 
development in the first half of the year. At present, the company is seeking 
strategic investors in the North American to develop local market. But he did

Related stock : (327)